14 employees
I2o Therapeutics is a biotech company that develops safe and effective oral formulations of therapies.
2019
$4M
from 3 investors over 3 rounds
i2o Therapeutics raised $4M on April 9, 2020
Investors: Sanofi Ventures, Touchdown Ventures and JDRF T1D Fund